期刊文献+

舒芬太尼联合丙泊酚在肝硬化患者无痛胃镜检查中的应用 被引量:6

在线阅读 下载PDF
导出
摘要 目的探讨舒芬太尼联合丙泊酚静脉麻醉用于肝硬化患者无痛胃镜的有效性和安全性。方法将我院100例自愿行无痛胃镜检查的肝硬化住院患者随机分为2组,即A组(舒芬太尼复合丙泊酚组)和B组(芬太尼复合丙泊酚组),行静脉全麻,观察并记录意识消失时间、意识恢复时间,同时观察有无呛咳、膈肌痉挛等不良反应及血压、心电图、血氧饱度变化等。结果两组患者检查时间、丙泊酚用量比较差异无统计学意义。但丙泊酚+舒芬太尼组的意识恢复时间和定向力恢复时间均短于丙泊酚+芬太尼组,P<0.05)。结论丙泊酚复合舒芬太尼用于肝硬化患者无痛胃镜检查麻醉较复合芬太尼起效快、苏醒迅速,患者更舒适,麻醉过程平稳,是临床值得推荐的方法。
出处 《中国医药指南》 2012年第21期194-195,共2页 Guide of China Medicine
  • 相关文献

参考文献5

二级参考文献42

  • 1张晓琴,蔡英敏,薛荣亮,赵莉.舒芬太尼在老年患者全麻诱导中对血液动力学的影响[J].临床麻醉学杂志,2005,21(8):525-526. 被引量:88
  • 2陈丽萍,周旋光,黄世清,李淑蓉.丙泊酚伍用麻黄碱在胃镜检查中的应用[J].临床麻醉学杂志,2005,21(10):702-703. 被引量:10
  • 3李红灵,黄涛,刘杰民,胡浩,杨浩羿,邓云坤,蒋克东,姚亚雷.老年患者1465例无痛性胃镜检查分析[J].贵州医药,2006,30(2):158-159. 被引量:6
  • 4王彩艳,徐红,王丽波,孙岩,张建广,徐为然,药云波.静脉麻醉在食管胃底静脉曲张内镜诊疗术中的临床应用(附80例报告)[J].吉林医学,2006,27(9):1004-1005. 被引量:4
  • 5庄心良,曾因明,陈伯銮,主编.现代麻醉学.第3版.北京:人民卫生出版社,2004:2610-2612.
  • 6Patel HH,Fryer ER,Gross ER,et al.12-lipoxygenase in opioid-induced delayed cardioprotection:gene array,mass spectrometric,and pharmacological analyses[J].Circ Res,2003,92:676.
  • 7Jermoe Guitton.Possible Involvement of Multiple Cytochrome P45OS in Fentanyl and Sufentanil Metabolism as Opposed to Alfentani[J].Biochemical Pharmacology,1997,53(11):1613.
  • 8Robert J,Hudson,et al.pharmacokinetics of sufentanil in patients undergoing abdominal aortic surgery[J].Anesthesiology,1989,70:426.
  • 9Bovill JG,Peter SS,Cordeila LB,et al.The pharmacokinetics of sufentanil in surgical patients[J].Anesthesiology,1984,61:502.
  • 10Lehmann KA,Sipakis K,Gasparini R,et al.Pharmacokinetics of sufentanil in general surgical patients under different conditions of anaesthesia[J].Acta Anaesthesiol Stand,1993,37(2):176.

共引文献109

同被引文献63

  • 1伊丁丁.舒芬太尼复合丙泊酚在无痛胃镜检查中的应用[J].职业与健康,2007,23(14):1274-1274. 被引量:3
  • 2王茹,孙绪德,韩丽春,张贵和,高昌俊,陈蕾.异丙酚复合小剂量舒芬太尼用于无痛胃镜麻醉的临床观察[J].实用医学杂志,2007,23(18):2943-2944. 被引量:25
  • 3苟俊明.无痛胃镜检查患者心理状态分析.医学信息,2013,27:555.
  • 4Miller AH, Ancoli-Israel S, Bower JE, et al. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oneol, 2008,26:971 -982.
  • 5郑海燕,郑海珍,肖仲祥,等.丙泊酚联合瑞芬太尼用于肝硬化患者体内药代动力学的研究.海峡药学,2011,23(6):251-253.
  • 6Huang ZY, Chen G, Hao XY, et al. Outcomes of non-anatomic liver resection for hepatocellular carcinoma in the patients with liver cir- rhosis and analysis of prognostic factors. Langenbecks Arch Surg, 2011,396(2):193-199.
  • 7Do RK, Chandarana H, Felker E, et al. Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging:Value of normalized apparent diffusion coefficient using the spleen as reference organ. AJR Am J Roentgenol, 2010,195(03):671-676.
  • 8Liu F, Cai LY, Zhong L, et al. Model for end-stage liver disease combined with serum prealbumin to predict the prognosis of patients with decompensated liver cirrhosis. J Dig Dis, 2010,11(6):352-357.
  • 9Sawaki A,Mizuno N,Hoki N,et al. Diagnosis of gastricsubmucosal tumors using endoscopic ultrasound guidedfine needle aspiration [ J ]. J Clin Oncol ( Metting Ab-stract) ,2008,26(Suppl 15) :4574.
  • 10Ito H,Inoue H, Ryozawa S, et al. Fine-needle aspirationbiopsy and endoscopic ultrasound for pretreatment patho-logical diagnosis of gastricgastrointestinal stromal tumors[J ]. Gastroenterol Res Pract, 2012 ,2012 : 139083.

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部